Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GE Healthcare to conduct breast imaging technology trials

GE Healthcare to conduct breast imaging technology trials

8th June 2010

GE Healthcare is allying with a number of medical facilities to trial a new technology which is intended to improve breast cancer detection rates.

The company will partner with the Tel Aviv Sourasky Medical Center and Hamilton Health Sciences Hospital in Ontario to conduct clinical studies of its gamma camera-based Molecular Breast Imaging (MBI) system.

This device replaces the standard NaI detectors normally used in such technology with cadmium zinc telluride imaging functionality.

Its breast imaging functions are based on accumulation of a radioactive tracer in hypermetabolic cancer cells, while the MBI system has already demonstrated an encouraging performance in early clinical analysis.

Nathan Hermony, GE Healthcare’s nuclear medicine global manager, said: “This technology is intended to improve early detection in women who are at high risk for developing breast cancer, or in women with dense breasts who are less likely to benefit from conventional mammography.”

This comes after the company last week launched its SenoBright Contrast Enhanced Spectral Mammography technology, which is also optimised for analysis of dense tissue.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.